Literature DB >> 17038705

Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh.

Caryn Bern1, Josef Amann, Rashidul Haque, Rajib Chowdhury, Mustakim Ali, Katie M Kurkjian, Louise Vaz, Yukiko Wagatsuma, Robert F Breiman, W Evan Secor, James H Maguire.   

Abstract

Annual leishmanin skin test (LST) surveys were conducted in a visceral leishmaniasis-endemic Bangladeshi community from 2002 through 2004, using Leishmania infantum antigen from the same manufacturer and batch. In 2002, 530 (35%) of 1,532 had positive LST results; the prevalence increased with increasing age. The LST result was positive in 24 (51%) of 47, 18 (72%) of 25, and 11 (85%) of 13 kala-azar patients treated in the previous 1-11, 12-23, and 24-35 months. A positive LST result in 2002 was associated with protection against subsequent kala-azar (P < 0.0001). In 2003-2004, decreased antigen sensitivity was observed. Among 686 participants, 34% were LST-positive in 2002, 29% in 2003, and 19% in 2004. Of 63 cured kala-azar patients, 70% were positive in 2002, 53% in 2003, and only 30% in 2004. Among 171 participants tested with both antigens, L. infantum study antigen sensitivity was 70% compared with L. amazonensis antigen. Our data underscore the need for better production, standardization, and documentation of sensitivity, potency, and stability of leishmanin antigens.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038705

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

1.  Antileishmania immunological tests for asymptomatic subjects living in a visceral leishmaniasis-endemic area in Brazil.

Authors:  Luciana Almeida Silva; Héctor Dardo Romero; Gabriel Antônio Nogueira Nascentes; Roberto Teodoro Costa; Virmondes Rodrigues; Aluízio Prata
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

2.  Quantiferon-Leishmania as an epidemiological tool for evaluating the exposure to Leishmania infection.

Authors:  Nevin Turgay; I Cuneyt Balcioglu; Seray Ozensoy Toz; Yusuf Ozbel; Stephen L Jones
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

3.  Endemic transmission of visceral leishmaniasis in Bhutan.

Authors:  Thinley Yangzom; Israel Cruz; Caryn Bern; Daniel Argaw; Margriet den Boer; Iván Dario Vélez; Sujit K Bhattacharya; Ricardo Molina; Jorge Alvar
Journal:  Am J Trop Med Hyg       Date:  2012-10-22       Impact factor: 2.345

Review 4.  Of cattle, sand flies and men: a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination.

Authors:  Caryn Bern; Orin Courtenay; Jorge Alvar
Journal:  PLoS Negl Trop Dis       Date:  2010-02-09

5.  Asymptomatic Leishmania infantum infection in an area of northwestern Italy (Piedmont region) where such infections are traditionally nonendemic.

Authors:  Alberto Biglino; Cesare Bolla; Erika Concialdi; Anna Trisciuoglio; Angelo Romano; Ezio Ferroglio
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

6.  Interferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept study.

Authors:  Kamlesh Gidwani; Stephen Jones; Rajiv Kumar; Marleen Boelaert; Shyam Sundar
Journal:  PLoS Negl Trop Dis       Date:  2011-04-19

7.  Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control.

Authors:  Anette Stauch; Ram Rup Sarkar; Albert Picado; Bart Ostyn; Shyam Sundar; Suman Rijal; Marleen Boelaert; Jean-Claude Dujardin; Hans-Peter Duerr
Journal:  PLoS Negl Trop Dis       Date:  2011-11-29

8.  Prevalence and determinants of Leishmania major infection in emerging and old foci in Tunisia.

Authors:  Jihene Bettaieb; Amine Toumi; Sadok Chlif; Bilel Chelghaf; Aicha Boukthir; Adel Gharbi; Afif Ben Salah
Journal:  Parasit Vectors       Date:  2014-08-20       Impact factor: 3.876

9.  Appropriate screening for leishmaniasis before immunosuppressive treatments.

Authors:  Antonio Cascio; Chiara Iaria
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

Review 10.  A review of the leishmanin skin test: A neglected test for a neglected disease.

Authors:  Jessica Carstens-Kass; Kayla Paulini; Patrick Lypaczewski; Greg Matlashewski
Journal:  PLoS Negl Trop Dis       Date:  2021-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.